RecruitingNCT06145828

Clinical Application of Cytokine Adsorption Technique in AIDS Patients With Severe Pneumonia and/or Septic Shock

Clinical Application of Cytokine Adsorption Technology in AIDS Patients With Severe Pneumonia and/or Septic Shock: An Observational Study.


Sponsor

Guangzhou 8th People's Hospital

Enrollment

60 participants

Start Date

Oct 23, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Observing the Real-World Application Effectiveness of Cytokine Immune Adsorption Technology in AIDS Patients with Severe Pneumonia or septic shock.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study tests a special blood filtration technique called cytokine adsorption — which removes harmful inflammatory proteins from the bloodstream — in people with AIDS who have developed severe pneumonia or septic shock (life-threatening infection). **You may be eligible if...** - You have confirmed HIV infection that has progressed to AIDS (CD4 count below 200 or an AIDS-defining illness) - You are between 18 and 65 years old - You have been diagnosed with severe pneumonia or septic shock meeting established medical criteria **You may NOT be eligible if...** - You have a condition affecting the central nervous system (e.g., brain lesions), severe liver disease, or cirrhosis - You have an active tumor (cancer related to AIDS or unrelated) - You are pregnant or breastfeeding - You have severe heart, lung, liver, or kidney disease unrelated to AIDS - You have a history of alcohol abuse or drug use - The researcher judges that your overall condition would interfere with the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICECytokine Adsorption

During treatment with cytokine adsorption cartridge, the patient's blood is passed through these cartridges, which contain substances that can adsorb specific cytokines. Excess cytokines are captured and removed by these substances, and then the cleansed blood is returned to the patient's body.


Locations(1)

Guangzhou Eighth People's Hospital, Guangzhou Medical University

Guangzhou, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06145828


Related Trials